Court, “Dong-A ST’s first Baraclude generic did not infringe patent right”

The court raised a hand of Dong-A ST at the patent infringement trial of ‘Baraclude’ between BMS and Dong-A ST.

It means ‘Baracle,’ a generic launched by Dong-A ST did not infringe the Baraclude’s substance patent.

Baracle Tab was launched on September 7, a month before the expiration date of the Baraclude substance patent on October 9, 2015.

The court ruled there was no problem on the Don...